Siegemund A - Search Results

1

Prolactin receptor signaling during platelet activation.

Wallaschofski H, Kobsar A, Koksch M, Siegemund A, Hentschel B, Tuschy U, Lohmann T, Sokolova O, Eigenthaler M. Wallaschofski H, et al. Among authors: siegemund a. Horm Metab Res. 2003 Apr;35(4):228-35. doi: 10.1055/s-2003-39479. Horm Metab Res. 2003. PMID: 12778366

2

Coagulation, fibrinolysis and platelet P-selectin expression in peripheral vascular disease.

Koksch M, Zeiger F, Wittig K, Siegemund A, Reininger CB, Pfeiffer D, Ruehlmann C. Koksch M, et al. Among authors: siegemund a. Eur J Vasc Endovasc Surg. 2001 Feb;21(2):147-54. doi: 10.1053/ejvs.2000.1294. Eur J Vasc Endovasc Surg. 2001. PMID: 11237788 Free article.

3

Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia.

Grünewald M, Siegemund A, Grünewald A, Konegan A, Koksch M, Griesshammer M. Grünewald M, et al. Among authors: siegemund a. Haemophilia. 2002 Nov;8(6):768-75. doi: 10.1046/j.1365-2516.2002.00686.x. Haemophilia. 2002. PMID: 12410645

4

Absence of compensatory platelet activation in patients with severe haemophilia, but evidence for a platelet collagen-activation defect.

Grünewald M, Siegemund A, Grünewald A, Konegen A, Koksch M, Griesshammer M. Grünewald M, et al. Among authors: siegemund a. Platelets. 2002 Dec;13(8):451-8. doi: 10.1080/0953710021000059422. Platelets. 2002. PMID: 12487778 Free article.

5

Plasmatic coagulation and fibrinolytic system alterations in PNH: relation to clone size.

Grünewald M, Siegemund A, Grünewald A, Schmid A, Koksch M, Schöpflin C, Schauer S, Griesshammer M. Grünewald M, et al. Among authors: siegemund a. Blood Coagul Fibrinolysis. 2003 Oct;14(7):685-95. doi: 10.1097/00001721-200310000-00011. Blood Coagul Fibrinolysis. 2003. PMID: 14517495

6

Differences in platelet activation by prolactin and leptin.

Wallaschofski H, Kobsar A, Sokolova O, Siegemund A, Stepan H, Faber R, Eigenthaler M, Lohmann T. Wallaschofski H, et al. Among authors: siegemund a. Horm Metab Res. 2004 Jul;36(7):453-7. doi: 10.1055/s-2004-825727. Horm Metab Res. 2004. PMID: 15305227 Clinical Trial.

7

Enhanced platelet activation by prolactin in patients with ischemic stroke.

Wallaschofski H, Lohmann T, Hild E, Kobsar A, Siegemund A, Spilcke-Liss E, Hentschel B, Stumpf C, Daniel WG, Garlichs CD, Eigenthaler M. Wallaschofski H, et al. Among authors: siegemund a. Thromb Haemost. 2006 Jul;96(1):38-44. doi: 10.1160/TH05-09-0634. Thromb Haemost. 2006. PMID: 16807649

8

Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction.

Desch S, Siegemund A, Scholz U, Adam N, Eitel I, de Waha S, Fürnau G, Lurz P, Wetzel S, Schuler G, Thiele H. Desch S, et al. Among authors: siegemund a. Clin Res Cardiol. 2012 Feb;101(2):117-24. doi: 10.1007/s00392-011-0372-6. Epub 2011 Oct 21. Clin Res Cardiol. 2012. PMID: 22015616 Clinical Trial.

9

The effect of different anticoagulants on thrombin generation.

Petros S, Siegemund T, Siegemund A, Engelmann L. Petros S, et al. Among authors: siegemund t, siegemund a. Blood Coagul Fibrinolysis. 2006 Mar;17(2):131-7. doi: 10.1097/01.mbc.0000214708.73374.ce. Blood Coagul Fibrinolysis. 2006. PMID: 16479195

10

Influence of factor V HR2 on thrombin generation and clinical manifestation in rare bleeding disorders.

Strey RF, Siegemund A, Siegemund T, Schubert C, Schuster G, Wulff K, Herrmann FH. Strey RF, et al. Among authors: siegemund t, siegemund a. Pathophysiol Haemost Thromb. 2005;34(6):279-83. doi: 10.1159/000093108. Pathophysiol Haemost Thromb. 2005. PMID: 16772740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters